Cardiology Research and Practice / 2012 / Article / Tab 3

Review Article

Telemonitoring in Chronic Heart Failure: A Systematic Review

Table 3

Data measured, hospitalization rates and costs, primary endpoints, and all-cause mortality of trials.

Physiological parameters measuredCost of hospitalization per patient (telemonitoring {TM} group versus control group)All-cause mortality (TM group versus control group)Hospitalization rates or percentages (%) in TM group versus control groupPrimary endpoints

Dendale et al. [21]Wa, BPb, HRc1382€ ± 3384 versus 747€ ± 2137 ( )5% versus 17.5% ( )0.24 versus 0.42 ( )All-cause mortality
Wade et al. [22]Wa, BPbNot reported3.7 versus 3.9 ( )34.8% versus 32.2% ( )Hospital admission, emergency department visit or death
Scherr et al. [23]Wa, BPb, HRc, DdNot reported0 in intervention group, 1 in control group54% RRe reduction, Confidence Interval 7 to 79%, ( ) in favor of intervention groupCardiovascular mortality or rehospitalization for worsening HFf
Mortara et al. [24]Wa, HRc, SAPg, DSh, ASi, OSj, changes in therapy, blood resultsNot reportedNot reported separatelyItaly versus Poland and UK: 3 versus 11% ( ). Poland: 9 versus 3% ( )Bed-days/year, Death+hospitalization due to HFf
Dar et al. [25]Wa, BPb, HRc, POk, questions about symptomsNot reportedNot reported36% versus 25%Days alive and out of hospital, all-cause hospitalizations
Antonicelli et al. [26]Wa, BPb, HRc, 24 h urine output, weekly ECGNot reported3 cases versus 5 cases, non significant9 cases versus 25 cases ( )Rate of mortality and hospitalization
Cleland et al. [27]Wa, BPb, HRc, ECGNot reported29% versus 27% (telephone support-{TS} group) versus 45% at 1st year ( )47% (TM) versus 49% (TS) versus 54%Days lost due to death or all cause hospitalization
Giordano et al. [28]Wa, BPb, ECG, drug dosage843€ ± 1733 versus 1298€ ± 2322 (−35%, )9% versus 14%24% versus 36% (RR = 0.57, CI: 0.38 to 0.82; )Unplanned hospital admission for cardiovascular reason
Goldberg et al. [29]Wa, symptom questionsNot reported8% versus 18.4% ( ) versus ( )180-day hospital readmission rate
Tompkins and Orwat[30]Wa, BPb, HRc, POk, symptom questions12% reduction of total cost in TM group ( )Not reportedLower hospital admissions in TM group, incidence rate ratio = 0.87Inpatient hospital utilization
Soran et al. [31]Wa, symptom questionsNot reported7.0% versus 11.2% ( )46.8% versus 42.5% ( )Cardiovascular death or rehospitalization for heart failure
Koehler et al. [32]Wa, BPb, ECG,Not reported54 cases versus 55 cases (hazard ratio 0.97, CI = 0.67 to 1.41, )486 events versus 394 events (hazard ratio 1.12, CI = 0.91 to 1.37, )Death from any cause

aW: weight, bBP: arterial blood pressure, cHR: heart rate, dD: dosage of heart failure medication, eRR: relative risk, fHF: heart failure gSAP: systolic arterial pressure, hDS: dyspnoea score, iAS: asthenia score, jOS: oedema score, kPO: pulse oximetry.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.